The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...

Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

Gustoff said “Katie’s Law” is court-tested, and has been found constitutional by the U.S. Supreme Court. He said other states, including Texas, Virginia, Indiana and California have seen significant ...

Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...

Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the 'Company” or 'Cannabix”) and Omega Laboratories ...

The Vitamin D Testing Market has emerged as an essential segment within the global diagnostics industry as healthcare systems ...

This is an excerpt of an article from STAT, the health and medicine news site that’s a partner to the Globe. For a full version of this story and related coverage, visit STAT. Sign up for STAT’s free ...

Rocket Lab entered January riding high after securing an $816 million U.S. Space Force contract in December. Morgan Stanley upgraded the stock to "Overweight" with a $105 price target, while Bank of ...

Results from laboratory tests on cannabis samples randomly collected from associations regulated and licensed by the Authority for the Responsible Use of Cannabis (ARUC), as well as from samples of ...

Rocket Lab Corp (NASDAQ: RKLB) shares are sliding on Thursday as investors continue to react to Congress’s decision to decline funding for a planned 2031 Mars sample-return mission tied to NASA’s ...

NASA wants to send a rocket to Mars to retrieve samples collected by the Perseverance rover. Rocket Lab offered to do the mission for $4 billion. Congress just said "no." As Science.org reported ...